• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk of Cardiovascular Morbidity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Survivors.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症幸存者心血管疾病发病和死亡风险
JAMA Dermatol. 2025 Apr 1;161(4):391-398. doi: 10.1001/jamadermatol.2024.5881.
2
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.Stevens-Johnson 综合征/中毒性表皮坏死松解症患者住院死亡率风险预测模型的建立与验证-ABCD-10
JAMA Dermatol. 2019 Apr 1;155(4):448-454. doi: 10.1001/jamadermatol.2018.5605.
3
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.全身性治疗史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)和 SJS/TEN 重叠综合征。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.
4
Epidemiological Characteristics and Prognostic Scoring in Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: Insights from a 17-Year Burn Center Experience.中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征的流行病学特征及预后评分:来自一家烧伤中心17年经验的见解
Medicina (Kaunas). 2025 Jan 3;61(1):66. doi: 10.3390/medicina61010066.
5
Lifetime risk, life expectancy, loss-of-life expectancy and lifetime healthcare expenditure for Stevens-Johnson syndrome/toxic epidermal necrolysis in Taiwan: follow-up of a nationwide cohort from 2008 to 2019.台湾史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的终生风险、预期寿命、预期寿命损失和终生医疗保健支出:2008 年至 2019 年全国队列的随访。
Br J Dermatol. 2023 Oct 25;189(5):553-560. doi: 10.1093/bjd/ljad234.
6
Long-term cardiovascular outcomes among adult survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective cohort study using TriNetX.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症成年幸存者的长期心血管结局:一项使用TriNetX的回顾性队列研究
Clin Exp Dermatol. 2025 Jun 25;50(7):1355-1361. doi: 10.1093/ced/llaf046.
7
Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States.美国儿童史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症
J Am Acad Dermatol. 2017 May;76(5):811-817.e4. doi: 10.1016/j.jaad.2016.12.024. Epub 2017 Mar 9.
8
Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的发病率:一项基于韩国全国健康保险数据库的全国性人群研究。
PLoS One. 2016 Nov 11;11(11):e0165933. doi: 10.1371/journal.pone.0165933. eCollection 2016.
9
Stevens-Johnson syndrome and toxic epidermal necrolysis associated with increased risk of developing psychiatric disorders: A retrospective population-based cohort study in Taiwan.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症与精神障碍发病风险增加相关:台湾一项基于人群的回顾性队列研究。
J Dermatol. 2022 Oct;49(10):979-987. doi: 10.1111/1346-8138.16487. Epub 2022 Jun 10.
10
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults.成人表皮松解症的发病率、住院及长期死亡率和后遗症
JAMA Dermatol. 2024 Dec 1;160(12):1288-1296. doi: 10.1001/jamadermatol.2024.3575.

本文引用的文献

1
Epidermal necrolysis: a chronic disease associated with loss-of-life expectancy and lifetime healthcare expenditure.表皮坏死松解症:一种与预期寿命缩短和终身医疗保健支出相关的慢性疾病。
Br J Dermatol. 2023 Oct 25;189(5):505-506. doi: 10.1093/bjd/ljad254.
2
Lifetime risk, life expectancy, loss-of-life expectancy and lifetime healthcare expenditure for Stevens-Johnson syndrome/toxic epidermal necrolysis in Taiwan: follow-up of a nationwide cohort from 2008 to 2019.台湾史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的终生风险、预期寿命、预期寿命损失和终生医疗保健支出:2008 年至 2019 年全国队列的随访。
Br J Dermatol. 2023 Oct 25;189(5):553-560. doi: 10.1093/bjd/ljad234.
3
Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus.表皮松解性坏死的后期阶段和后遗症管理:一项国际性、多学科的基于 DELPHI 的共识。
Orphanet J Rare Dis. 2023 Feb 22;18(1):33. doi: 10.1186/s13023-023-02631-7.
4
Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications.伴有严重眼部并发症的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的发病机制。
Front Med (Lausanne). 2021 Nov 17;8:651247. doi: 10.3389/fmed.2021.651247. eCollection 2021.
5
Clinical Characteristics of Patients With Chronic Stevens-Johnson Syndrome Treated at a Major Tertiary Eye Hospital Within the United Kingdom.在英国一家大型三级眼科医院接受治疗的慢性史蒂文斯-约翰逊综合征患者的临床特征
Front Med (Lausanne). 2021 May 24;8:644795. doi: 10.3389/fmed.2021.644795. eCollection 2021.
6
Effect of older age on complications and mortality in inpatients with Stevens-Johnson syndrome or toxic epidermal necrolysis.
J Am Acad Dermatol. 2022 Mar;86(3):665-667. doi: 10.1016/j.jaad.2021.02.046. Epub 2021 Feb 20.
7
Disseminated intravascular coagulopathy: a complication of Stevens-Johnson syndrome/toxic epidermal necrolysis.弥散性血管内凝血:史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的一种并发症。
Int J Dermatol. 2021 Feb;60(2):185-189. doi: 10.1111/ijd.15370. Epub 2020 Dec 17.
8
A Dynamic Model for Predicting Survival up to 1 Year After Ischemic Stroke.缺血性脑卒中后 1 年生存预测的动态模型。
J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105133. doi: 10.1016/j.jstrokecerebrovasdis.2020.105133. Epub 2020 Jul 18.
9
Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症中的弥散性血管内凝血。
J Am Acad Dermatol. 2021 Jun;84(6):1782-1791. doi: 10.1016/j.jaad.2020.08.065. Epub 2020 Aug 20.
10
Long-term sequelae from Stevens-Johnson syndrome/toxic epidermal necrolysis in a large retrospective cohort.一项大型回顾性队列研究中史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的长期后遗症
J Am Acad Dermatol. 2021 Mar;84(3):784-786. doi: 10.1016/j.jaad.2020.04.020. Epub 2020 Apr 11.

史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症幸存者心血管疾病发病和死亡风险

Risk of Cardiovascular Morbidity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Survivors.

作者信息

Chiu Hsien-Yi, Chiu Ying-Ming

机构信息

Department of Medical Research, National Taiwan University Hsin-Chu Hospital, Hsinchu, Taiwan.

Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.

出版信息

JAMA Dermatol. 2025 Apr 1;161(4):391-398. doi: 10.1001/jamadermatol.2024.5881.

DOI:10.1001/jamadermatol.2024.5881
PMID:39969876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11840681/
Abstract

IMPORTANCE

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) cause diffuse epidermal detachment and necrosis. Patients who survive the initial SJS/TEN episodes are affected by various sequelae.

OBJECTIVE

To investigate the risks of cardiovascular morbidity and mortality in SJS/TEN survivors.

DESIGN, SETTING, AND PARTICIPANTS: This was a nationwide population-based cohort study using data from Taiwan's National Health Research Institute Database linked to the National Register of Death databases for 1998 to 2021. Survivors of SJS/TEN were identified and matched with non-SJS/TEN participants by age, sex, and Charlson Comorbidity Index. Data analysis was performed from November 2023 to June 2024.

EXPOSURE

Cerebrovascular accidents (CVA) or ischemic heart disease (IHD) after SJS/TEN survival.

MAIN OUTCOMES AND MEASURES

Cox proportional hazards models were used to estimate the hazard ratios (HRs) of CVA and IHD morbidity and mortality after SJS/TEN survival.

RESULTS

The CVA cohort included 10 571 SJS/TEN survivors (mean [SD] age, 56.1 [18.5] years; 5358 females [50.7%] and 5213 males [49.3%]). The IHD cohort included 11 084 SJS/TEN survivors (mean [SD] age, 56.6 [18.6] years; 5561 females [50.2%] and 5523 males [49.8%]). The Cox proportional hazards model and competing risk regression model showed that compared with non-SJS/TEN participants, patients with SJS/TEN had higher risks of cardiovascular morbidity (CVA: HR, 1.65 [95% CI, 1.57-1.72] and subdistribution HR [sHR], 1.40 [95% CI, 1.33-1.46]; IHD: HR, 1.58 [95% CI, 1.51-1.65] and sHR, 1.32 [95% CI, 1.26-1.38]) and death due to cardiovascular disease (CVA: HR, 1.69; 95% CI, 1.46-1.96; IHD: HR, 1.55; 95% CI, 1.32-1.82). The increased cardiovascular mortality risks peaked at 1 year after SJS/TEN and persisted for 4 to 7 years. Older survivors and survivors admitted to an intensive care unit at SJS/TEN diagnosis had significantly higher cardiovascular mortality risk.

CONCLUSIONS AND RELEVANCE

In this cohort study, SJS/TEN had a lasting association with cardiovascular function after the acute phase. This suggests a need to mitigate the elevated cardiovascular morbidity and mortality risks among survivors. Further research using databases or registries with more comprehensive clinical data are needed to validate these results.

摘要

重要性

史蒂文斯 - 约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)会导致弥漫性表皮剥脱和坏死。在SJS/TEN初始发作中存活下来的患者会受到各种后遗症的影响。

目的

调查SJS/TEN幸存者发生心血管疾病的发病率和死亡率风险。

设计、设置和参与者:这是一项基于全国人口的队列研究,使用了台湾国立卫生研究院数据库与1998年至2021年国家死亡登记数据库的数据。通过年龄、性别和查尔森合并症指数确定SJS/TEN幸存者,并与非SJS/TEN参与者进行匹配。数据分析于2023年11月至2024年6月进行。

暴露因素

SJS/TEN存活后发生的脑血管意外(CVA)或缺血性心脏病(IHD)。

主要结局和测量指标

使用Cox比例风险模型估计SJS/TEN存活后CVA和IHD发病及死亡的风险比(HRs)。

结果

CVA队列包括10571名SJS/TEN幸存者(平均[标准差]年龄,56.1[18.5]岁;5358名女性[50.7%]和5213名男性[49.3%])。IHD队列包括11084名SJS/TEN幸存者(平均[标准差]年龄,56.6[18.6]岁;5561名女性[50.2%]和5523名男性[49.8%])。Cox比例风险模型和竞争风险回归模型显示,与非SJS/TEN参与者相比,SJS/TEN患者发生心血管疾病的风险更高(CVA:HR,1.65[95%置信区间,1.57 - 1.72]和亚分布HR[sHR],1.40[95%置信区间,1.33 - 1.46];IHD:HR,1.58[95%置信区间, 1.51 - 1.65]和sHR,1.32[95%置信区间,1.26 - 1.38])以及心血管疾病导致的死亡风险(CVA:HR,1.69;95%置信区间,1.46 - 1.96;IHD:HR,1.55;95%置信区间,1.32 - 1.82)。心血管死亡率增加的风险在SJS/TEN后1年达到峰值,并持续4至7年。年龄较大的幸存者以及在SJS/TEN诊断时入住重症监护病房的幸存者心血管死亡风险显著更高。

结论和相关性

在这项队列研究中,SJS/TEN在急性期后与心血管功能存在持久关联。这表明有必要降低幸存者中心血管疾病发病率和死亡率升高的风险。需要使用具有更全面临床数据的数据库或登记处进行进一步研究以验证这些结果。